These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 34209019)

  • 21. Idiopathic pulmonary fibrosis (IPF): disease pathophysiology, targets, and potential therapeutic interventions.
    Saha P; Talwar P
    Mol Cell Biochem; 2024 Sep; 479(9):2181-2194. PubMed ID: 37707699
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Endoplasmic reticulum stress and unfolded protein response in diaphragm muscle dysfunction of patients with stable chronic obstructive pulmonary disease.
    Barreiro E; Salazar-Degracia A; Sancho-Muñoz A; Aguiló R; Rodríguez-Fuster A; Gea J
    J Appl Physiol (1985); 2019 Jun; 126(6):1572-1586. PubMed ID: 30998124
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Azithromycin has enhanced effects on lung fibroblasts from idiopathic pulmonary fibrosis (IPF) patients compared to controls [corrected].
    Krempaska K; Barnowski S; Gavini J; Hobi N; Ebener S; Simillion C; Stokes A; Schliep R; Knudsen L; Geiser TK; Funke-Chambour M
    Respir Res; 2020 Jan; 21(1):25. PubMed ID: 31941499
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Newly defined acute exacerbation of idiopathic pulmonary fibrosis with surgically-proven usual interstitial pneumonia: risk factors and outcome.
    Okuda R; Hagiwara E; Katano T; Ikeda S; Sekine A; Kitamura H; Baba T; Okudela K; Ohashi K; Ogura T
    Sarcoidosis Vasc Diffuse Lung Dis; 2019; 36(1):39-46. PubMed ID: 32476935
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chronic Expression of a Clinical
    Rodriguez L; Tomer Y; Carson P; Dimopoulos T; Zhao M; Chavez K; Iyer S; Huang L; Ebert C; Sereda L; Murthy A; Trujillo G; Beers MF; Katzen J
    Am J Respir Cell Mol Biol; 2023 Apr; 68(4):358-365. PubMed ID: 36473455
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Real-life experiences in a single center: efficacy of pirfenidone in idiopathic pulmonary fibrosis and fibrotic idiopathic non-specific interstitial pneumonia patients.
    Feng H; Zhao Y; Li Z; Kang J
    Ther Adv Respir Dis; 2020; 14():1753466620963015. PubMed ID: 33070705
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular markers of telomere dysfunction and senescence are common findings in the usual interstitial pneumonia pattern of lung fibrosis.
    Lee JS; La J; Aziz S; Dobrinskikh E; Brownell R; Jones KD; Achtar-Zadeh N; Green G; Elicker BM; Golden JA; Matthay MA; Kukreja J; Schwartz DA; Wolters PJ
    Histopathology; 2021 Jul; 79(1):67-76. PubMed ID: 33432658
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Iron deposition and increased alveolar septal capillary density in nonfibrotic lung tissue are associated with pulmonary hypertension in idiopathic pulmonary fibrosis.
    Kim KH; Maldonado F; Ryu JH; Eiken PW; Hartman TE; Bartholmai BJ; Decker PA; Yi ES
    Respir Res; 2010 Apr; 11(1):37. PubMed ID: 20398288
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of Natural Products through Inhibiting Endoplasmic Reticulum Stress on Attenuation of Idiopathic Pulmonary Fibrosis.
    Deng J; Liu J; Chen W; Liang Q; He Y; Sun G
    Drug Des Devel Ther; 2024; 18():1627-1650. PubMed ID: 38774483
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of angiotensin II type 1 and G-protein-coupled Mas receptor expression on the pulmonary performance of patients with idiopathic pulmonary fibrosis.
    Raupp D; Fernandes RS; Antunes KH; Perin FA; Rigatto K
    Peptides; 2020 Nov; 133():170384. PubMed ID: 32777324
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ATF4 Mediates Mitochondrial Unfolded Protein Response in Alveolar Epithelial Cells.
    Jiang D; Cui H; Xie N; Banerjee S; Liu RM; Dai H; Thannickal VJ; Liu G
    Am J Respir Cell Mol Biol; 2020 Oct; 63(4):478-489. PubMed ID: 32551949
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ceramide expression and cell homeostasis in chronic obstructive pulmonary disease.
    Scarpa MC; Baraldo S; Marian E; Turato G; Calabrese F; Saetta M; Maestrelli P
    Respiration; 2013; 85(4):342-9. PubMed ID: 23018286
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Change in forced vital capacity and associated subsequent outcomes in patients with newly diagnosed idiopathic pulmonary fibrosis.
    Reichmann WM; Yu YF; Macaulay D; Wu EQ; Nathan SD
    BMC Pulm Med; 2015 Dec; 15():167. PubMed ID: 26714746
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Premature lung aging and cellular senescence in the pathogenesis of idiopathic pulmonary fibrosis and COPD/emphysema.
    Chilosi M; Carloni A; Rossi A; Poletti V
    Transl Res; 2013 Sep; 162(3):156-73. PubMed ID: 23831269
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Azithromycin attenuates myofibroblast differentiation and lung fibrosis development through proteasomal degradation of NOX4.
    Tsubouchi K; Araya J; Minagawa S; Hara H; Ichikawa A; Saito N; Kadota T; Sato N; Yoshida M; Kurita Y; Kobayashi K; Ito S; Fujita Y; Utsumi H; Yanagisawa H; Hashimoto M; Wakui H; Yoshii Y; Ishikawa T; Numata T; Kaneko Y; Asano H; Yamashita M; Odaka M; Morikawa T; Nakayama K; Nakanishi Y; Kuwano K
    Autophagy; 2017 Aug; 13(8):1420-1434. PubMed ID: 28613983
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chemokine Receptor 2-targeted Molecular Imaging in Pulmonary Fibrosis. A Clinical Trial.
    Brody SL; Gunsten SP; Luehmann HP; Sultan DH; Hoelscher M; Heo GS; Pan J; Koenitzer JR; Lee EC; Huang T; Mpoy C; Guo S; Laforest R; Salter A; Russell TD; Shifren A; Combadiere C; Lavine KJ; Kreisel D; Humphreys BD; Rogers BE; Gierada DS; Byers DE; Gropler RJ; Chen DL; Atkinson JJ; Liu Y
    Am J Respir Crit Care Med; 2021 Jan; 203(1):78-89. PubMed ID: 32673071
    [No Abstract]   [Full Text] [Related]  

  • 37. Endoplasmic reticulum stress in alveolar epithelial cells is prominent in IPF: association with altered surfactant protein processing and herpesvirus infection.
    Lawson WE; Crossno PF; Polosukhin VV; Roldan J; Cheng DS; Lane KB; Blackwell TR; Xu C; Markin C; Ware LB; Miller GG; Loyd JE; Blackwell TS
    Am J Physiol Lung Cell Mol Physiol; 2008 Jun; 294(6):L1119-26. PubMed ID: 18390830
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sensitization of the UPR by loss of PPP1R15A promotes fibrosis and senescence in IPF.
    Monkley S; Overed-Sayer C; Parfrey H; Rassl D; Crowther D; Escudero-Ibarz L; Davis N; Carruthers A; Berks R; Coetzee M; Kolosionek E; Karlsson M; Griffin LR; Clausen M; Belfield G; Hogaboam CM; Murray LA
    Sci Rep; 2021 Nov; 11(1):21584. PubMed ID: 34732748
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The JAK2 pathway is activated in idiopathic pulmonary fibrosis.
    Milara J; Hernandez G; Ballester B; Morell A; Roger I; Montero P; Escrivá J; Lloris JM; Molina-Molina M; Morcillo E; Cortijo J
    Respir Res; 2018 Feb; 19(1):24. PubMed ID: 29409529
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Activated MCTC mast cells infiltrate diseased lung areas in cystic fibrosis and idiopathic pulmonary fibrosis.
    Andersson CK; Andersson-Sjöland A; Mori M; Hallgren O; Pardo A; Eriksson L; Bjermer L; Löfdahl CG; Selman M; Westergren-Thorsson G; Erjefält JS
    Respir Res; 2011 Oct; 12(1):139. PubMed ID: 22014187
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.